Henry Wilke Murray, M.D.

Infectious Disease
Henry Murray

Dr. Murray received his BA degree from Cornell University and his MD from Cornell University Medical College. He trained in Internal Medicine at The New York Hospital, where he was also Chief Resident, and at The Johns Hopkins Hospital. He obtained clinical infectious diseases training at George Washington University School of Medicine and post-doctoral research training in immunology at Rockefeller University. In 1979, Dr. Murray returned to the Division of Infectious Diseases at Weill Cornell Medical College where he established his research laboratory in experimental visceral leishmaniasis and host defense which has now been supported by NIH for nearly 30 years, and he was also Division Chief (1983-1995). He established Cornell's NIH AIDS Clinical Trials Group and the Cornell Clinical Trials Unit, and was Associate Chairman for Clinical Research in the Department of Medicine (1995-2007). Dr. Murray established and directs the Arthur Ashe AIDS Endowment, co-chairs the Department's Quality Assurance Committee and formerly co-directed the Kala-Azar Medical Research Center in India. He is editor of Tropimed-U.S., a travel medicine web site, and attends on the Infectious Diseases clinical service and at Cornell's Travel Medicine Clinic.


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • Aetna - Weill Cornell [POS]
  • Health Republic
  • Medicaid
  • Medicare
  • Oscar
  • Rockefeller University - CoreSource


Dr. Murray has published 216 original research and clinical publications and review articles, 10 invited editorials and 64 books and book chapters. Recent selected publications include:

Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 366:1561, 2005.

Sundar S, Maurya R, Singh RK, Bharti K, Chakravarty J, Parekh A, Rai M, Kumar K, Murray HW. Rapid noninvasive diagnosis in Indian visceral leishmaniasis: comparison of two strips formats in detection of anti-K39 antibody. J Clin Microbiol 44:251, 2006.

Murray HW, Xiang Z, Ma X. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. Am J Trop Med Hyg 74:1013, 2006.

Murray HW, Tsai CW, Liu J, Ma X. Responses to Leishmania donovani in mice deficient in IL-12, IL-12/IL-23 or IL-18. Infect Immun 74:4370, 2006.

Murray HW, Tsai CW, Liu J, Ma X. Visceral Leishmania donovani infection in IL-13-/- mice. Infect Immun 74:2487, 2006.

Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW. Amphotericin B treatment in Indian visceral leishmaniasis: response to 15 daily vs. alternate-day infusions. Clin Infect Dis 45:556, 2007.

Miro JM, Murray HW, Katlama C. Toxoplasmosis. In AIDS Therapy (eds. R. Dolin, H. Masur, M. Saag), Churchill Livingstone, Inc., 3rd Edition, New York, chapter 37, 2008

Sundar S, Rai M, Chakravarty J, Agrawal D, Agrawal N, Vaillant M, Olliaro P, Murray HW. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by with short-course miltefosine. Clin Infect Dis 47:1000, 2008.

Murray HW. Accelerated control of visceral Leishmania donovani infection in IL-6-/- mice. Infect Immun 76:4088, 2008.

Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for Indian visceral leishmaniasis. N Eng J Med 362: 504, 2010.

Fusco DN, Downs JN, Satlin MJ, Pahuja M, Ramos L, Fleckenstein L, Murray HW. Non-oral ivermectin treatment for disseminated strongyloidiasis. Am J Trop Med Hyg 83:879, 2010.

Murray HW. Treatment of visceral leishmaniasis in 2010: direction from Bihar State,

India. Future Microbiol 5:1301, 2010.

Leyritana KT, Saniel MC, Carpo BG, Murray HW. New World cutaneous leishmaniasis in a traveler: first documented case in the Philippines. Acta Medica Philippina 45:73, 2011.

Murray HW. Leishmaniasis in the United States: treatment in 2012. Amer J Trop Med Hyg 86:434, 2012.

Murray HW, Zhang Y, Zhang Y, Raman VS, Reed SG, Ma X. Regulatory actions of TLR2 and TLR4 in Leishmania donovani infection in the liver. Infect Immun 81:2318, 2013.

Honors and Awards

1981 Rockefeller Foundation Career Development Award

1983 Chief, Division of Infectious Diseases

1984 American Society for Clinical Investigation

1989 Squibb Award for Outstanding Achievement, Infectious Diseases Society of America

1992 NIH AIDS Program Advisory Committee

1994 Association of American Physicians

1995 Associate Chairman (Clinical Research), Department of Medicine

2002 NIH Tropical Medicine and Parasitology Study Section

2005 Arthur R. Ashe, Jr. Professor of Medicine

2006 Chairman, Quality Assurance Committee, Department of Medicine